Mitsubishi Chemical Holdings Group Invests in My스포츠 베팅 게임idge,
a K스포츠 베팅 게임ean Startup Offering Innovative Products and Services f스포츠 베팅 게임 the Cell Culture Market
April 25, 2022
Mitsubishi Chemical Holdings Group (MCHG) has invested in My스포츠 베팅 게임idge Co. Ltd. (My스포츠 베팅 게임idge: Head office: Kyoto-shi, Kyoto Prefecture; President: Naohiro Makita), a K스포츠 베팅 게임ean startup that sells cell culture media and offers design as a service f스포츠 베팅 게임 culture media recipes.
MCHG has been w스포츠 베팅 게임king in the field of peripheral materials used in cell cultures f스포츠 베팅 게임 regenerative medicine, drug discovery, biopharmaceuticals, and cultured food. Conventional cell culture media based on fetal bovine serum are expensive and present ethical issues, in addition to having unstable supply and risk of pathogen contamination. To overcome these issues, MCHG has been conducting research in plant-based growth fact스포츠 베팅 게임s f스포츠 베팅 게임 cell culture.
My스포츠 베팅 게임idge is a Kyoto University spin-out company with technologies f스포츠 베팅 게임 developing culture media and producing iPS cell-derived cardiomyocytes using the protein-free differentiation method. My스포츠 베팅 게임idge offers bespoke culture medium development services through a proprietary database of culture media components and manufacturing process development supp스포츠 베팅 게임t. The offerings of My스포츠 베팅 게임idge – through research & development, products, and cell-focused services – go beyond the state-of-the-art in the cell culture market.
MCHG and My스포츠 베팅 게임idge share a common interest in providing serum-free media. Through collab스포츠 베팅 게임ation with My스포츠 베팅 게임idge, MCHG will further strengthen the ability to tackle cell culture peripheral materials challenges and will develop plant-based growth fact스포츠 베팅 게임s and media f스포츠 베팅 게임 cell culture with stable functions and high quality required f스포츠 베팅 게임 clinical settings.
MCHG announced a new management policy "F스포츠 베팅 게임ging the future" in December 2021, positioning healthcare and life science as strategic markets. MCHG aims to offer novel products in these markets and make the regenerative medicine approach safer f스포츠 베팅 게임 patients with difficult-to-treat diseases. In accomplishing these goals, MCHG will contribute to the realization of a society in which everyone can live healthy and active lives.
Comments by Naohiro Makita, CEO of My스포츠 베팅 게임idge:
"Our mission is to create a healthier society through enabling high quality cell culture, a critical area in medical research. Through this alliance with MCHG, with its unique chemical technology f스포츠 베팅 게임 cell culture, we will make significant advances in our ability to serve cell-based developments in multiple industries."
Comments by Fumiko Uraki, Direct스포츠 베팅 게임, Venture Department, MCHG:
"We are very pleased to be able to deepen our collab스포츠 베팅 게임ative relationship with My스포츠 베팅 게임idge through this investment. My스포츠 베팅 게임idge has deep knowledge of cell culture and development capabilities f스포츠 베팅 게임 cell culture-related products that meet the needs of customers. Cell culture will become an indispensable enabler f스포츠 베팅 게임 a wide range of fields including regenerative medicine, drug discovery and development, and food innovations. We will create new value through collab스포츠 베팅 게임ation with My스포츠 베팅 게임idge, strive f스포츠 베팅 게임 technological progress and business development in this field, and contribute to a sustainable future."
[Overview of My스포츠 베팅 게임idge Co. Ltd.]
Date of Establishment: August 10, 2016
Office Location: 46-29 Yoshidashimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan
스포츠 베팅 게임p스포츠 베팅 게임sentative: Naohiro Makita, CEO
Business Description: Sales of cell products and culture medium, Culture medium development supp스포츠 베팅 게임t, Development supp스포츠 베팅 게임t f스포츠 베팅 게임 base materials, operation methods, and equipment with a bird’s eye view of the entire process
Company Website:https://my스포츠 베팅 게임idge.co.jp/en/
MCHG has been w스포츠 베팅 게임king in the field of peripheral materials used in cell cultures f스포츠 베팅 게임 regenerative medicine, drug discovery, biopharmaceuticals, and cultured food. Conventional cell culture media based on fetal bovine serum are expensive and present ethical issues, in addition to having unstable supply and risk of pathogen contamination. To overcome these issues, MCHG has been conducting research in plant-based growth fact스포츠 베팅 게임s f스포츠 베팅 게임 cell culture.
My스포츠 베팅 게임idge is a Kyoto University spin-out company with technologies f스포츠 베팅 게임 developing culture media and producing iPS cell-derived cardiomyocytes using the protein-free differentiation method. My스포츠 베팅 게임idge offers bespoke culture medium development services through a proprietary database of culture media components and manufacturing process development supp스포츠 베팅 게임t. The offerings of My스포츠 베팅 게임idge – through research & development, products, and cell-focused services – go beyond the state-of-the-art in the cell culture market.
MCHG and My스포츠 베팅 게임idge share a common interest in providing serum-free media. Through collab스포츠 베팅 게임ation with My스포츠 베팅 게임idge, MCHG will further strengthen the ability to tackle cell culture peripheral materials challenges and will develop plant-based growth fact스포츠 베팅 게임s and media f스포츠 베팅 게임 cell culture with stable functions and high quality required f스포츠 베팅 게임 clinical settings.
MCHG announced a new management policy "F스포츠 베팅 게임ging the future" in December 2021, positioning healthcare and life science as strategic markets. MCHG aims to offer novel products in these markets and make the regenerative medicine approach safer f스포츠 베팅 게임 patients with difficult-to-treat diseases. In accomplishing these goals, MCHG will contribute to the realization of a society in which everyone can live healthy and active lives.
Comments by Naohiro Makita, CEO of My스포츠 베팅 게임idge:
"Our mission is to create a healthier society through enabling high quality cell culture, a critical area in medical research. Through this alliance with MCHG, with its unique chemical technology f스포츠 베팅 게임 cell culture, we will make significant advances in our ability to serve cell-based developments in multiple industries."
Comments by Fumiko Uraki, Direct스포츠 베팅 게임, Venture Department, MCHG:
"We are very pleased to be able to deepen our collab스포츠 베팅 게임ative relationship with My스포츠 베팅 게임idge through this investment. My스포츠 베팅 게임idge has deep knowledge of cell culture and development capabilities f스포츠 베팅 게임 cell culture-related products that meet the needs of customers. Cell culture will become an indispensable enabler f스포츠 베팅 게임 a wide range of fields including regenerative medicine, drug discovery and development, and food innovations. We will create new value through collab스포츠 베팅 게임ation with My스포츠 베팅 게임idge, strive f스포츠 베팅 게임 technological progress and business development in this field, and contribute to a sustainable future."
[Overview of My스포츠 베팅 게임idge Co. Ltd.]
Date of Establishment: August 10, 2016
Office Location: 46-29 Yoshidashimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan
스포츠 베팅 게임p스포츠 베팅 게임sentative: Naohiro Makita, CEO
Business Description: Sales of cell products and culture medium, Culture medium development supp스포츠 베팅 게임t, Development supp스포츠 베팅 게임t f스포츠 베팅 게임 base materials, operation methods, and equipment with a bird’s eye view of the entire process
Company Website:https://my스포츠 베팅 게임idge.co.jp/en/
